Cardiovascular magnetic resonance for patients with COVID-19

Tools

Item Type:	Review
Title:	Cardiovascular magnetic resonance for patients with COVID-19
Creators Name:	Petersen, S.E., Friedrich, M.G., Leiner, T., Elias, M.D., Ferreira, V.M., Fenski, M., Flamm, S.D., Fogel, M., Garg, R., Halushka, M.K., Hays, A.G., Kawel-Boehm, N., Kramer, C.M., Nagel, E., Ntusi, N.A.B., Ostenfeld, E., Pennell, D.J., Raisi-Estabragh, Z., Reeder, S.B., Rochitte, C.E., Starekova, J., Suchá, D., Tao, Q., Schulz-Menger, J. and Bluemke, D.A.
Abstract:	COVID-19 is associated with myocardial injury caused by ischemia, inflammation, or myocarditis. Cardiovascular magnetic resonance (CMR) is the noninvasive reference standard for cardiac function, structure, and tissue composition. CMR is a potentially valuable diagnostic tool in patients with COVID-19 presenting with myocardial injury and evidence of cardiac dysfunction. Although COVID-19-related myocarditis is likely infrequent, COVID-19-related cardiovascular histopathology findings have been reported in up to 48% of patients, raising the concern for long-term myocardial injury. Studies to date report CMR abnormalities in 26% to 60% of hospitalized patients who have recovered from COVID-19, including functional impairment, myocardial tissue abnormalities, late gadolinium enhancement, or pericardial abnormalities. In athletes post-COVID-19, CMR has detected myocarditis-like abnormalities. In children, multisystem inflammatory syndrome may occur 2 to 6 weeks after infection; associated myocarditis and coronary artery aneurysms are evaluable by CMR. At this time, our understanding of COVID-19-related cardiovascular involvement is incomplete, and multiple studies are planned to evaluate patients with COVID-19 using CMR. In this review, we summarize existing studies of CMR for patients with COVID-19 and present ongoing research. We also provide recommendations for clinical use of CMR for patients with acute symptoms or who are recovering from COVID-19.
Keywords:	Cardiovascular Magnetic Resonance, COVID-19, Ischemia, Multisystem Inflammatory Syndrome, Myocardial Injury, Myocarditis, SARS-CoV-2
Source:	JACC: Cardiovascular Imaging
ISSN:	1936-878X
Publisher:	Elsevier
Volume:	15
Number:	4
Page Range:	685-699
Date:	April 2021
Additional Information:	Crown Copyright © 2022 Published by Elsevier on behalf of the American College of Cardiology Foundation. All rights reserved.
Official Publication:	https://doi.org/10.1016/j.jcmg.2021.08.021
External Fulltext:	View full text on PubMed Central
PubMed:	View item in PubMed

Repository Staff Only: item control page